heinrich dreismann   zoominfocom heinrich dreismann  myriad genetics  inc  zoominfocom bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version mygn heinrich dreismann insider trades for myriad genetics inc bulletin investor alert new york markets open in market snapshot analyst ratings expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close myriad genetics inc nasdaq mygn go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus myriad genetics inc after hours  quotes are delayed by  min jul    pm mygn quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual heinrich dreismann dr heinrich dreismann is independent director at interpace diagnostics group inc independent director at ignyta inc independent director at myriad genetics inc lead independent director at singulex inc a member at american society for microbiology a member at european diagnostic manufacturers association and a member at new york academy of sciences he is on the board of directors at interpace diagnostics group inc ignyta inc advandx inc adarza biosystems inc spinomix sa historx inc myriad genetics inc sirius genomics inc singulex inc magellan diagnostics inc iconix biosciences inc genenews ltd biocision llc biohelix corp celula inc and stratos genomics inc dr dreismann was previously employed as independent director by med biogene inc chief executive officer by fastraq inc chief executive officer by vectrant technologies inc headglobal business development by roche diagnostics president  chief executive officer by roche molecular systems inc and executive chairman by homestead clinical corp he also served on the board at shrink nanotechnologies inc nanogen inc chondrogene ltd and oxford biodynamics ltd he received his graduate degree from the university of münster and a doctorate degree from the university of münster transactions date shares transaction value     award at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr mark c capone president chief executive officer  director mr gary a king executive vice presidentinternational operations mr r bryan riggsbee chief financial officer treasurer  executive vp mr robert gardner harrison chief information officer dr jerry s lanchbury chief scientific officer mr richard s swartz executive vice president ms nicole lambert general managerurology business unit ms vicki fish general managerdermatology mr scott gleason investor relations contact mr ronald s rogers evpcorporate communications  media contact ms jayne b hart executive vice presidenthuman resources mr richard m marsh secretary executive vp  general counsel dr john tannahill henderson chairman dr walter a gilbert vice chairman mr lawrence c best independent director ms s louise phanstiel independent director dr heinrich dreismann independent director dr dennis h langer independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york pre marketstatecountryuk london open marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest aexxonmobil q revenue  bln vs  bln astarbucks shares sink but analysts are optimistic about future growth aexxonmobil q eps  cents vs  cents ameet the ‘hamilton’ actors who play up to  roles in the hit show aamazon stock price target raised to  from  at jp morgan aplantronics downgraded to neutral from overweight at jp morgan aqep resources stock price target cut to  from  at jp morgan aqep resources downgraded to neutral from overweight at jp morgan arenaissancere stock price target cut to  from  at jp morgan axl group stock price target raised to  from  at jp morgan aabbvie shares surge  on q profit revenue beats arenaissancere downgraded to neutral from overweight at jp morgan axl group upgraded to overweight from neutral at jp morgan astarbucks stock price target cut to  from  at jp morgan agoodyear tires stock dives after slashed profit outlook offsets inline earnings awatch out ‘kids’ are making the most money in this stock market astock market set to extend fresh tech rout as amazon disappoints gdp data ahead ashares of video game maker activision blizzard down more than  aintel earnings have message for amd and nvidia ‘bring it on’ aaarons shares up nearly  in friday premarket trading loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  heinrich dreismann phd executive profile  biography  bloomberg july    am et biotechnology company overview of ignyta inc snapshotpeople  overviewboard memberscommittees executive profile heinrich dreismann phddirector ignyta incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background dr heinrich dreismann also known as heiner phd has been the chief executive officer of vectrant technologies inc since  dr dreismann was a venture partner at sv life sciences advisers llc since  he joined sv life sciences advisers on october   he was part of the biotechnology team and focused on in vitro diagnostics diagnostics biotechnology biopharmaceuticals medical devices and instrumentation and healthcare services he served as the head  of diagnostics at metastat inc since october  and served as its diagnostic consultant from october  to august   he served as an interim chief executive officer of genenews limited from may   to july   he served as an executive advisor at ignyta inc since january  he had a successful career at the roche group from  to  he served as the chief executive officer and president of roche molecular systems rms inc from  to  he cofounded integrated diagnostics inc in  and served as its executive chairman dr dreismann served as the president of roche molecular systems inc since january  and as its chief executive officer from  to  and oversaw significant expansion of its product portfolio he held a number of additional positions at roche diagnostics corporation including head of global business development head of business unit of pcr europe since  head of business unit microbiology and vice president of manufacturing as well as rd positions in microbiology and infectious diseases and in manufacturing and served as business unit manager of pcr and microbiology he served as head of integration office of roche diagnostics where he managed the merger of boehringer mannheim at roche diagnostics in his last role at rms he oversaw the doubling of the molecular in vitro diagnostics business to over  billion and had overall responsibilities for business corporate and rd functions as well as the respective staff he led the introduction of pcrbased tests in europe as early as  and witnessed firsthand the industry growth over the last two decades he is a veteran of the molecular diagnostics industry and has a wealth of experience and contacts dr dreismann is a seasoned executive with more than  years of experience in the health care industry and is regarded as a pioneer in the early adoption of the polymerase chain reaction pcr technique he serves as the chairman of the board at spinomix sa dr dreismann serves as the chairman of optimal medicine ltd he served as the chairman of theragenetics ltd and smart holograms limited he served as the chairman of business advisory board at shrink nanotechnologies inc he serves on the boards of several innovative public and private diagnostic companies he has been a director of ignyta inc since october   dr dreismann has been a director of magellan diagnostics inc since august  celula inc since  dr dreismann has been a director at myriad genetics inc since june  he serves as a director of medcision inc stratos genomics inc biocision llc biohelix corporation vectrant technologies and alliedpath he has been an independent director of advandx inc since march   he has been a director of singulex inc since january  and serves as its lead independent director he has been member of business advisory board at d signatures inc since october  he served as a director of adarza biosystems inc he served as a lead director of genenews limited from may   to november   and its independent director from september   to november   he served as a director of shrink nanotechnologies inc from june   to november   he served as a director of integrated diagnostics inc he served as a director of interpace diagnostics group inc since august   until september   he served as a director of sirius genomics inc since november  he served as a director at med biogene inc from may   to september   and iconix biosciences inc since october   he served as a director of historx inc since october  and oxford biodynamics plc oxford biodynamics limited since october  he served as a director of ngen inc from october   to august  he served as a member of business advisory board at shrink nanotechnologies inc dr dreismann has a postdoctoral fellowship from the french center for nuclear research in saclay near paris france dr dreismann did his postdoctoral studies in microbial genetics at the centre detudes nucleaires de saclay france dr dreismann holds ms degree in biology from westfaelische wilhelms university muenster and a phd in microbiologymolecular biology from westfaelische wilhelms university muenster summa cum laude in read full background corporate headquarters  towne centre courtsan diego california united statesphone fax  board members memberships directorbiocision llcdirectorbiohelix corporationdirectorstratos genomics incchairmanspinomix sadirectormedcision incpresentlead independent directorsingulex incpresentdirectormagellan diagnostics incpresentdirectorcelula incpresentdirectormyriad genetics incpresentindependent directoradvandx incpresentdirectorignyta inc education ms westfälische wilhelmsuniversität münsterphd westfälische wilhelmsuniversität münster other affiliations iconix biosciences incmyriad genetics incngen incinterpace diagnostics group incsv health investors llcgenenews limitedroche diagnostics corporationroche molecular systems incwestfälische wilhelmsuniversität münsteradvandx incsmart holograms limitedhistorx incsingulex incmagellan diagnostics incsirius genomics incmed biogene incintegrated diagnostics inctheragenetics ltdcelula incadarza biosystems incoxford biodynamics plcbiocision llcshrink nanotechnologies incbiohelix corporationstratos genomics incmetastat incspinomix sad signatures incmedcision inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation total annual cash compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact ignyta inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close heinrich dreismann phd  biography log in email password remember forgot password  become a member for free sign up sign up new membersign up for free new customerdiscover our portfolios united states united kingdom france deutschland schweiz de suisse fr settings dynamic quotes  offon markets equities north americaeuropeasiaoceaniamiddle east» more equities indexes dow jonessp nasdaq tsx compftse » more indexes currency  forex eur  usdgbp  usdusd  jpyusd  cadaud  usd» more currencies commodities goldcrude oil wticrude oil brentsilverplatinum» more commodities news latest news companiesmarketseconomycurrency  forexcommoditiesinterest ratesbusiness leadersfinancial calendareconomic calendar listed company analyst recorumorsiposcapital markets transactionsnew contractsprofits warningsappointmentspress releaseseventscorporate actions sector news energybasic materialsindustrialsconsumer cyclicalconsumer noncyclicalfinancialshealthcaretechnologytelecommunications servicesutilities analysis all analysiscommentariesindex analysisstock trading strategiescommodity analysisforex analysis stock picks all stock picks portfolios my portfolio virtual portfolios traders portfolios european portfoliousa portfolioasian portfolio screeners market screener homefundamental analyse top investor ratingtop trading ratingtop consensusgrowth stocksyield stockslow valuations technical analysis oversold stocksoverbought stocksclose to resistancesclose to supportsaccumulation phasemost volatile stocks watchlists my watchlists watchlists top lists yield stocksgrowth stocksundervalued stocks top  flop top news most read newshot news top fundamentals top capitalizationtop yieldtop pertop consensustop fundamentals top technicals top rsiunusual volumestop gapstop stim top movers top usatop canadatop uktop germanytop europetop asia tools market screenerdynamic chartfinancial calendareconomic calendarsector researchcurrency converter our services premium accessdiscover our services traders homepage    news    business leaders    business leaders biography business leaders latest newscompaniesmarketseconomy  forexcommoditiesinterest ratesbusiness leadersfinance professionalscalendarsectors homeall newsmost read newsbusiness leaders biography heinrich dreismann phd age  public asset   usdlinked companies  myriad genetics inc  ignyta inc summary  dr heinrich dreismann is a member at american society for microbiology a member at european diagnostic manufacturers association and a member at new york academy of scienceshe is on the board of directors at ignyta inc advandx inc adarza biosystems inc spinomix sa historx inc myriad genetics inc singulex inc biocision llc celula inc magellan biosciences inc novellusdx ltd nucleix ltd and stratos genomics inc dr dreismann was previously employed as an independent director by interpace diagnostics group inc an independent director by med biogene inc chief executive officer by fastraq inc lead director by genenews ltd chief executive officer by vectrant technologies inc headglobal business development by roche diagnostics president  chief executive officer by roche molecular systems inc and executive chairman by homestead clinical corphe also served on the board at sirius genomics inc shrink nanotechnologies inc magellan diagnostics inc ngen inc iconix biosciences inc biohelix corp chondrogene ltd and oxford biodynamics plche received his graduate degree from the university of münster and a doctorate degree from the university of münster current positions of heinrich dreismann phd  nametitle since myriad genetics incadvanced medical equipment  technology independent director  ignyta incbiotechnology  medical research independent director singulex inc director biocision llc director historx inc director celula inc director advandx inc director adarza biosystems inc director stratos genomics inc director nucleix ltd director spinomix sa director magellan biosciences inc director novellusdx ltd director new york academy of sciences member american society for microbiology member european diagnostic manufacturers association member  holdings of heinrich dreismann phd  nameequitiesvaluation myriad genetics inc mygn advanced medical equipment  technology  usd genenews ltd gen biotechnology  medical research  usd ignyta inc rxdx biotechnology  medical research  usd heinrich dreismann phd personal network  namelinked companies dennis h langer myriad genetics incadvandx inc rajiv indravadan modi american society for microbiologynew york academy of sciences stephen l rose stratos genomics incsingulex inc erez chimovits novellusdx ltdnucleix ltd jerry s lanchbury myriad genetics inc richard m marsh myriad genetics inc jonathan e lim ignyta inc mark c capone myriad genetics inc james l freddo ignyta inc robert gardner harrison myriad genetics inc most read news  djmukesh ambani  reliances ambani launches lowcost mobile phone for india djindra nooyi  pepsico stretches managers at top  wsj  li kashing  li kashings cki to buy german energy metering firm ista djbernard arnault  lvmhs profit rises  in first half  rupert murdoch  as murdoch waits sky cuts operating costs to protect profits djmeg whitman  meg whitman steps down from hp board djdavid simon  executive pay falls for big mall owners as retail storm rages on djjeff bezos  amazons jeff bezos becomes worlds richest person pdjelon musk  top company news of the day djwilbur ross  more crossborder commerce more news   people and ownership     advertisement heinrich dreismann phd  connections  pernix therapeutics holdings inc dennis h langer novavax inc rajiv indravadan modi novus therapeutics inc erez chimovits dicerna pharmaceuticals inc dennis h langer ignyta inc jonathan e limjames l freddo myriad genetics inc dennis h langerjerry s lanchburyrichard m marshmark c caponerobert gardner harrison gujarat alkalies  chemicals limited rajiv indravadan modi nucleix ltd erez chimovits stratos genomics inc stephen l rose braeburn pharmaceuticals inc dennis h langer sancilio pharmaceuticals co inc dennis h langer sirna therapeutics inc dennis h langer orbimed capital llc erez chimovits georgetown university school of medicine dennis h langer novellusdx ltd erez chimovits cadila pharmaceuticals ltd rajiv indravadan modi american society for microbiology rajiv indravadan modi targeted microwave solutions inc rajiv indravadan modi senet inc stephen l rose ignyta operating inc jonathan e lim popular business leaders  bernard arnault mary barra jeff bezos lloyd blankfein michael bloomberg yannick bolloré warren buffett jeanpaul clozel gary cohn jamie dimon ralph dommermuth sebastian ebel john edwards david einhorn jeff fettig mark fields carlos ghosn terry gou david henry carl icahn li kashing michel landel daniel loeb jack ma lakshmi mittal rupert murdoch elon musk peter nicholas john paulson nelson peltz georges plassat hasso plattner thomas rabe giuseppe recchi wolfgang reitzle wilbur ross charles schwab igor sechin masayoshi son pascal soriot george soros rupert stadler bernard tapie patrick thomas tim westergren john williamson thomas wilson dieter zetsche mark zuckerberg az business leaders traderscom marketsnewsanalysisstock picksportfoliosscreenerswatchliststop  floptoolsour servicesabout surperformance sascontact usadvertiselegal informationsabout usstay connected facebooktwitterpartners börse aktien kurse und nachrichtenbest tweets copyright   surperformance all rights reserved slave heinrich dreismann and harry glorikian  genomeweb skip to main content rss feeds twitter linkedin log in join now business  policybusiness news research funding policy  legislation regulatory news reimbursement technologymicroarrays  multiplexing pcr informatics sequencing mass spec sample prep gene silencinggene editing researchgenetic research gene expression research epigenetics research proteomics  protein research cell biology research diagnosticsmolecular diagnostics companion diagnostics biomarker discovery  validation drug discovery  development clinical sequencing clinical proteomics disease areascancer infectious disease cardiovascular disease neurological  psychological disease metabolic disease autoimmune disease inherited disease reproductive health applied markets resourceswebinars white papers the scan career blog job listings new products people in the news conferences  events main menu enter your keywords home » resources » people in the news » heinrich dreismann and harry glorikian heinrich dreismann and harry glorikian oct   in a filing with the us securities and exchange commission interpace diagnostics announced the resignations of heinrich dreismann and harry glorikian from the companys board of directors the company stated that neither resignation was due to a disagreement with the company or matters relating to the companys operations policies or practices more like this jul   cynthia bens cynthia bens will join the personalized medicine coalition as vice president of public policy on august  bens comes to pmc after more than a decade with the alliance for aging research where she helped advocate for policies including the st century cures act the prescription drug user fee act and fda’s patientfocused drug development initiative prior to that she spent four years at the bipartisan government affairs firm the loeffler group and also worked as a staff assistant on capitol hill jul   rohit khanna waters said in a filing with the us securities and exchange commission this week that rohit khanna has resigned from his position as svp applied technology effective july   khanna will continue to serve as an svp of the company and as a member of the firms executive committee until his retirement on dec    jul   scott howell tenet diagnostics has appointed scott howell its cmo he was most recently executive medical director at heritage provider network he also continues to practice at kaiser permanente los angeles medical center in the addiction medicine department he was previously national senior medical director and chief medical officer network and population health optim insight regional cmo northeast region of americhoice and national medical director of managed care for aids healthcare foundation  jul   gene defelice alexandra snyder adaptive biotechnologies has appointed gene defelice to senior vice president and general counsel and alexandra snyder to translational medicine lead for adaptive researchdefelice has served as general counsel for several public healthcare and technology companies including as primary counsel at roche diagnostics he will join adaptives executive team to implement a legal infrastructure for clinical applications of nextgeneration sequencing technologiessnyder has joined adaptive from memorial sloan kettering cancer research center where she specialized in tumor immunogenomics and response to checkpoint blockade immunotherapy   jul   kieran murphy stephen kanovsky kieran murphy has resigned from the board of neogenomics following his appointment as president and ceo of ge healthcare neogenomics said in a document filed with the us securities and exchange commission that murphy resigned due to the time demands of his new job and added that it has appointed stephen kanovsky to fill murphys position on the board he is general counsel of ge unit global innovation of ge healthcare jul   thomas loewald thomas loewald senior vice president and chief commercial officer at thermo fisher scientific since early  will resign from the company effective september  he joined the firms explosives detection business in  and held various positions over the years including senior vice president and president of laboratory products prior to that he was vice president of sales and marketing for tyco international jul   mark stevenson mark stevenson has been promoted to executive vice president and chief operation officer of thermo fisher scientific effective august  in his new role he will oversee operations of the companys laboratory products and analytical instruments businesses in addition to the life sciences solutions business since  when thermo fisher acquired life technologies stevenson has been executive vice president and president of life sciences solutions prior to that he was president and chief operating officer of life technologies and before that he was president and coo of applied biosystems jul   hans bishop hans bishop has been elected to agilents board of directors bishop is cofounder president and ceo of juno therapeutics a seattlebased biopharmaceutical company he has also held a range of executive positions in the pharmaceutical industry including as coo at dendreon president of specialty medicine at bayer healthcare and global commercial head for chiron jul   daniel sikkema quanterix has appointed daniel sikkema as vice president of acclerator services for the companys new simoa accelerator lab a dedicated environment for biomarker research custom assay development and clinical sample testing sikkema will work to expand the reach of quanterixs accelerator lab services in neurology oncology immunooncology infectious disease inflammatory diseases and other therapeutic areas he has previously worked at frontage lab bristolmyers squibb wyeth merck sanofi pasteur and glaxosmithkline jul   stephen pereira stephen pereira has been appointed to immunovias scientific advisory board pereira is a professor of hepatology and gastroenterology at university college london and is an honorary consultant in pancreaticobiliary medicine at ucl hospitals and the royal free hospital  jul   daniel macarthur the american society of human genetics has named daniel macarthur as the first recipient of its early career award he is an assistant professor in the analytic and translational genetics unit at massachusetts general hospital and harvard medical school and the codirector of the medical and population genetics program at the broad institute the new award which comes with  in prize money recognizes contributions of genetics and genomics scientists in the first  years of their careers as independent investigators macarthur and his colleagues developed the exome aggregation consortium exac database and website and its successor the genome aggregation database gnomad he also published many scientific articles on identifying genes associated with rare diseases in particular muscular disorders jul   mary thistle enterome has appointed mary thistle to its board of directors as a nonexecutive director thistle currently serves as chief operating officer at dimension therapeutics and has also served as senior vp of business development at cubist pharmaceuticals prior to joining dimension in  thistle held leadership positions at viacell in addition to developing therapeutic products for rare and metabolic liver diseases enterome also develops diagnostics to support therapies in microbiomerelated diseases such as inflammatory bowel disease and cancer jul   arthur beaudet the american society of human genetics has named arthur beaudet the recipient of this years victor a mckusick leadership award the award recognizes individuals whose professional achievements have fostered and enriched the development of human genetics as well as its assimilation into the broader context of science medicine and health beaudet who will receive the award along with a  prize at the ashg annual meeting in october is the henry and emma mayer professor in the department of molecular and human genetics and the department of pediatrics at baylor college of medicine he is a member of the national academy of medicine and the national academy of sciences and has received several other awards for his work beaudet has published more than  articles in the scientific literature  jul   kári stefánsson the american society of human genetics has named kári stefánsson the winner of this years william allan award a prize established in  that recognizes a scientist for substantial and farreaching scientific contributions to human genetics stefánsson is the founder of icelands decode genetics which has conducted a largescale population genetics research project in iceland he has published more than  articles in the scientific literature and has received several awards for his work including the european society of human genetics award in  jul   matthias raquet oneservice a swiss company offering complete managed service solutions consulting and learning for the life science diagnostics and medical device industries has appointed matthias raquet as ceo raquet joins oneservice from qiagen where he has worked since  most recently as vice president and head of global service solutions and global customer management prior to qiagen he worked in various management roles at amersham pharmacia breaking news fluidigm ascendas genomics ink mdx development pact in china cancer dependency maps developed by two research teams errorprone dna repair implicated in analysis of cancer mutation signature clusters ancient genome sequences point to canaanite ancestry in presentday lebanese population qiagen q revenues grow  percent firm nudges up fullyear guidance biomatrica gets ceivd marks for sample collection tubes the scan embryos edited in us technology review reports that researchers in the us have used crispr to modify a number of human embryos true blue by introducing genes from butterfly peas and canterbury bells researchers in japan have developed a blue chrysanthemum according to npr all the plants plant researchers plan to sequence some  samples that represent the major plant clades scienceinsider reports this week in nature in nature this week a danish reference genome and more sponsorships about us advertise contact jobs subscribe privacy policy  copyright   genomeweb llc  all rights reserved people in the news heinrich dreismann harry glorikian mary alice mcmorrow gerald cox and more  genomeweb skip to main content rss feeds twitter linkedin log in join now business  policybusiness news research funding policy  legislation regulatory news reimbursement technologymicroarrays  multiplexing pcr informatics sequencing mass spec sample prep gene silencinggene editing researchgenetic research gene expression research epigenetics research proteomics  protein research cell biology research diagnosticsmolecular diagnostics companion diagnostics biomarker discovery  validation drug discovery  development clinical sequencing clinical proteomics disease areascancer infectious disease cardiovascular disease neurological  psychological disease metabolic disease autoimmune disease inherited disease reproductive health applied markets resourceswebinars white papers the scan career blog job listings new products people in the news conferences  events main menu enter your keywords home » people in the news heinrich dreismann harry glorikian mary alice mcmorrow gerald cox and more people in the news heinrich dreismann harry glorikian mary alice mcmorrow gerald cox and more oct    staff reporter heinrich dreismann and harry glorikianin a filing with the us securities and exchange commission interpace diagnostics announced the resignations of heinrich dreismann and harry glorikian from the companys board of directors the company stated that neither resignation was due to a disagreement with the company or matters relating to the companys operations policies or practicesmary alice mcmorrow get the full story this story is free for registered users registering provides access to this and other free content register now already have an accountlogin now breaking news fluidigm ascendas genomics ink mdx development pact in china cancer dependency maps developed by two research teams errorprone dna repair implicated in analysis of cancer mutation signature clusters ancient genome sequences point to canaanite ancestry in presentday lebanese population qiagen q revenues grow  percent firm nudges up fullyear guidance biomatrica gets ceivd marks for sample collection tubes the scan embryos edited in us technology review reports that researchers in the us have used crispr to modify a number of human embryos true blue by introducing genes from butterfly peas and canterbury bells researchers in japan have developed a blue chrysanthemum according to npr all the plants plant researchers plan to sequence some  samples that represent the major plant clades scienceinsider reports this week in nature in nature this week a danish reference genome and more sponsorships about us advertise contact jobs subscribe privacy policy  copyright   genomeweb llc  all rights reserved myriad genetics inc mygn director dreismann heinrichs insider stock buys and sells home homepage membership levels membership data coverage complete stock list founders message the book free trial screeners value screens allinone screener industry overview ben graham netnet undervalued predictable buffettmunger screener magic formula greenblatt historical low ps list historical low pb list peter lynch screen high short interest weekyy lows weekyy highs predictable companies sp  grid dividend stocks spin off list downloads  tools excel addin guruf manual of stocks™ download financial data download guru portfolios download stock pdfs download insider data api mobile app strategies performances buffettmunger undervalued predictable low ps low pb broadest owned most weighted gurus latest guru picks real time picks list of gurus personalize gurus portfolios scoreboard top  holdings view sector picks international picks aggregated portfolio consensus picks guru bargains hot picks industry trends geographic trend etfs options european shorting insiders all insiders ceo buyssales cfo buyssales insider cluster guruinsider double buys triple buyssales insider trends canadian insider dutch insider market market valuation economic data industry overview marketcapgdp valuation global market valuation shiller pe shiller pe by sectors buffett assets allocation by country usa australia canada china germany india japan uk more articles articles editors picks gurufocus research value ideas interviews with gurus top ranked value idea contest videos following authors submit articles writers wanted value contest winners submit articles online my articles conference value conference speakers locationvenue register after conference gathering free drinks tutorials tutorials  webinars faq contact us log in free signup log in day free trial subscribe free trial year refer a friend  earn  search compare search ▾ get day free trial my portfolios▾ portfolios overview create new portfolio portfolio contest my gurus▾ quick browse personalize my gurus premium gurus premium plus investors summarycanadian dutch ceo buys cfo buys insider cluster buys double buys triple buys data export trend saved usa canada ukireland europe asia oceania latin america africa currently selected show all countries ▾ purchase to select this region purchase  usa otcpk nas nyse arca otcbb amex bats purchase to select this region purchase  canada tsxv tsx xcnq purchase to select this region purchase  ukireland uk purchase to select this region purchase  europe germany france poland russia sweden turkey bosnia and herzegovina italy luxembourg switzerland belgium greece norway spain denmark bulgaria netherlands romania finland serbia austria croatia portugal slovakia cyprus macedonia slovenia ukraine hungary lithuania latvia malta iceland estonia czech republic all countries ▾ purchase to select this region purchase  asia india japan korea thailand hongkong china taiwan malaysia singapore israel indonesia pakistan vietnam philippines sri lanka kuwait nepal saudi jordan oman iran iraq united arab emirates kazakhstan bahrain all countries ▾ purchase to select this region purchase  oceania australia new zealand purchase to select this region purchase  latin america brazil mexico argentina chile peru columbia jamaica venezuela ecuador purchase to select this region purchase  africa south africa egypt nigeria mauritius morocco zimbabwe kenya tunisia ghana côte divoire set as default insider trades try insider screener myriad genetics inc mygn director dreismann heinrichs insider stock buys and sellsto find out why gurufocus thinks data on insider trades is interesting read can aggregated insider trading activities predict the market stocks that both gurus and insiders are buying can aggregated insider trading activities predict the market of different sectors filter by   default search insider trade go select to drill down all market capmicro cap small cap mid cap large cap mega cap sp  companies all sectorsbasic materials consumer cyclical financial services real estate consumer defensive healthcare utilities communication services energy industrials technology display those with at least          shares display stocks that are within please select        of please select week lowyear lowyear lowreal time insider typebuysellinsider sentiment chart recent filings activity total records    page          last   per page ▾      symbol company insider position date buysell shares trade price  cost  price changesince trade  yield  pe market cap m details mygnmyriad geneticsdreismann heinrichdirectorsell  link mygnmyriad geneticsdreismann heinrichdirectorsell  link mygnmyriad geneticsdreismann heinrichdirectorsell  link total records    page          last   per page ▾     add this list into my watchlistportfolio  add or remove tickers comma separated up to  symbols mygn  select destination portfolioyou need to log in to proceed  click the button to finish related news and stories m comment on m m comment on m m stocknote m comment on m m stocknote m comment on m m comment on m m comment on m m httpswwwlibraryf m fun m comment on m m momentalne je nad ly m comment on m m note of m m note of m  only the transactions in open market or private sale at the market prices are included other transactions such as conversion of derivative security or exercise of options are not included insiders are limited to only officers andor directors of the company select portfolios create a new portfolio why you are interested your selection and notes will be stored in your portfolio login to add portfolio get wordpress plugins for easy affiliate links on stock tickers and guru names  earn affiliate commissions by embedding gurufocus charts gurufocus affiliate program earn up to  per referral  learn more home  about   jobs   advertise    site map    term of use    privacy policy     rss    mobile app     email alerts    referral program    affiliate program    faq    contact us      gurufocuscom llc all rights reserved disclaimers gurufocuscom is not operated by a broker a dealer or a registered investment adviser under no circumstances does any information posted on gurufocuscom represent a recommendation to buy or sell a security the information on this site and in its related newsletters is not intended to be nor does it constitute investment advice or recommendations the gurus may buy and sell securities before and after any particular article and report and information herein is published with respect to the securities discussed in any article and report posted herein in no event shall gurufocuscom be liable to any member guest or third party for any damages of any kind arising out of the use of any content or other material published or available on gurufocuscom or relating to the use of or inability to use gurufocuscom or any content including without limitation any investment losses lost profits lost opportunity special incidental indirect consequential or punitive damages past performance is a poor indicator of future performance the information on this site and in its related newsletters is not intended to be nor does it constitute investment advice or recommendations the information on this site is in no way guaranteed for completeness accuracy or in any other way the gurus listed in this website are not affiliated with gurufocuscom llc stock quotes provided by interactive data fundamental company data provided by morningstar updated daily gf chat  × manage bookmarks close feedback dreismann heinrich top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active dreismann heinrich • danville ca how do i update this listing dreismann heinrich is based out of danville summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from dreismann heinrich enter your email address below and choose submit your email cancel contact info dreismann heinrich  golden oak ct danville ca     recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free